June 10, 2022
A California judge gave a final toss to investor litigation accusing GoodRx of inflating the health care technology company's initial public offering stock price by hiding news of a rival Amazon program in the works, saying Thursday a revised complaint still lacked facts showing the defendants knew of the competitor's plans.
January 10, 2022
Health care technology company GoodRx has escaped an investor suit accusing the company of keeping shareholders in the dark during its initial public offering about a competing Amazon program to also provide prescription drug discounts.